Renaissance Technologies - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 24 filers reported holding INHIBIKASE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$44
+69.2%
67,300
+29.4%
0.00%
Q4 2022$26
-100.0%
52,000
-58.3%
0.00%
Q3 2022$113,000
-31.5%
124,683
-43.8%
0.00%
Q2 2022$165,000
-40.9%
221,900
+17.7%
0.00%
Q1 2022$279,000
-5.7%
188,469
-6.3%
0.00%
Q4 2021$296,000201,2000.00%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 937,500$696,0000.97%
HAMILTON LANE ADVISORS LLC 165,635$123,0000.05%
Redmond Asset Management, LLC 122,682$91,0000.03%
Retirement Planning Co of New England, Inc. 64,606$47,0000.03%
Antara Capital LP 403,000$299,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$70,0000.01%
Koshinski Asset Management, Inc. 65,377$49,0000.01%
K.J. Harrison & Partners Inc 18,300$14,0000.00%
Warberg Asset Management LLC 14,493$11,0000.00%
Shay Capital LLC 10,708$8,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders